UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation

Case reports in hematology, 2021-07, Vol.2021, p.1-4

2021

Link zum Volltext

Verfügbarkeit prüfen

What Counts As 'Safe?': Exposure To Trauma And Violence Among Asylum Seekers From The Northern Triangle

Health affairs (Millwood, Va.), 2021-07, Vol.40 (7), p.1135-1144A

2021

Link zum Volltext

Verfügbarkeit prüfen

Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.769-771

2017

Link zum Volltext

Verfügbarkeit prüfen

Developing and adapting a patient-centered communication tool (UR-GOAL) for older patients with acute myeloid leukemia (AML) and their oncologist

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S15-S16

2021

Link zum Volltext

Verfügbarkeit prüfen

SIOG2021-0115 - Developing and adapting a patient-centered communication tool (UR-GOAL) for older patients with acute myeloid leukemia (AML) and their oncologist

Journal of geriatric oncology, 2021-12, Vol.12 (8), p.S15-S16

2021

Link zum Volltext

Verfügbarkeit prüfen

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation

Case reports in hematology, 2021, Vol.2021, p.5574766-5574766

2021

Link zum Volltext

Verfügbarkeit prüfen

KANSAS CITY'S ART MUSEUM PLAN

The American magazine of art, 1929-09, Vol.20 (9), p.498-502

HUSELTON, HOWARD E.

1929

Link zum Volltext

Verfügbarkeit prüfen

Kansas City's Parks and Boulevards

Art and progress, 1911-11, Vol.3 (1), p.386-391

Huselton, Howard E.

1911

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1861-1873

2008

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

Transplantation and cellular therapy, 2023-05, Vol.29 (5), p.328.e1-328.e6

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

Clinical cancer research, 2019-07, Vol.25 (13), p.3776-3783

2019

Link zum Volltext

Verfügbarkeit prüfen

5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists

Journal of medicinal chemistry, 2010-11, Vol.53 (21), p.7639-7646

2010

Link zum Volltext

Verfügbarkeit prüfen

SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.5358-5364

2005

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R)

Journal of medicinal chemistry, 2009-04, Vol.52 (7), p.2148-2152

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia

Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6531-6534

2009

Link zum Volltext

Verfügbarkeit prüfen

Structure–activity relationships of the 1-amino-3-(1 H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors

Bioorganic & medicinal chemistry letters, 2009-10, Vol.19 (19), p.5807-5810

2009

Link zum Volltext

Verfügbarkeit prüfen

5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT6 Receptor Antagonists

Journal of medicinal chemistry, 2010-03, Vol.53 (6), p.2521-2527

2010

Link zum Volltext

Verfügbarkeit prüfen

Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles

Bioorganic & medicinal chemistry, 2009-11, Vol.17 (22), p.7802-7815

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT1A Receptor Antagonists

Journal of medicinal chemistry, 2009-08, Vol.52 (15), p.4955-4959

2009

Link zum Volltext

Verfügbarkeit prüfen

5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT 6 Receptor Antagonists

Journal of medicinal chemistry, 2010-03, Vol.53 (6), p.2521-2527

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4551-4554

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia

Journal of medicinal chemistry, 2009, Vol.52 (21), p.6531-6534

2009

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT 1A Receptor Antagonists

Journal of medicinal chemistry, 2009-08, Vol.52 (15), p.4955-4959

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)
Berichte
(1)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(18)
Pharmacology & Pharmacy
(13)
Animals
(12)
Biological And Medical Sciences
(12)
Chemistry, Medicinal
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(12)
Structure-Activity Relationship
(12)
Humans
(11)
Rats
(9)
Administration, Oral
(7)
Chemistry
(6)
Physical Sciences
(6)
Chemistry, Organic
(4)
Mice
(4)
Piperazines - Pharmacology
(4)
Anti-Arrhythmia Agents - Pharmacology
(3)
Antiarythmic Agents
(3)
Atrial Fibrillation - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation

What Counts As 'Safe?': Exposure To Trauma And Violence Among Asylum Seekers From The Northern Triangle

Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation

Developing and adapting a patient-centered communication tool (UR-GOAL) for older patients with acute myeloid leukemia (AML) and their oncologist

SIOG2021-0115 - Developing and adapting a patient-centered communication tool (UR-GOAL) for older patients with acute myeloid leukemia (AML) and their oncologist

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation

KANSAS CITY'S ART MUSEUM PLAN

Kansas City's Parks and Boulevards

Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)

A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists

SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models

Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R)

Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia

Structure–activity relationships of the 1-amino-3-(1 H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors

5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT6 Receptor Antagonists

Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles

The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists

Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT1A Receptor Antagonists

5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT 6 Receptor Antagonists

Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents

Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia

Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT 1A Receptor Antagonists

The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT 1A Antagonists

Suchergebnisse filtern